Insider Trading activities of Transbiotec, Inc. (IMLE)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Transbiotec, Inc. (IMLE) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Transbiotec, Inc. since year 2005. Table 2 shows the detailed insider transactions of Transbiotec, Inc. since 2005. The reporting company's ticker symbol is IMLE. The reporting company's CIK number is 1425627.
The total value of stock buying since 2005 is $2,038,110.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Transbiotec, Inc. (IMLE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-08 53,741,595 $2,038,110 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Transbiotec, Inc. insiders (IMLE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-08-28 Lanphere Michael A. (V.P. of Legal Affairs) Buy 26,607,175 .05 1,383,573
2019-08-28 Mishal Devadatt M (Director) Buy 13,134,420 .00 52,537
2019-08-28 Bennington Charles Warren (CEO, President and Secretary) Buy 14,000,000 .04 602,000

Insider trading activities including stock purchases, stock sales, and option exercises of IMLE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Transbiotec, Inc. (symbol IMLE, CIK number 1425627) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month